Inari Medical is known for its mechanical thrombectomy solutions, including the FlowTriever System for pulmonary embolism treatment and the ClotTriever System for peripheral vessel thrombectomy.

Shares of Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) have been given an average rating of “Hold” by the fourteen brokerages that are currently covering the stock, MarketBeat reports. Twelve ...

Inari Medical reported strong revenue growth in ... Inari’s core products, FlowTriever and ClotTriever, are designed to treat blood clots without the need for thrombolytic drugs, differing ...

Charles Schwab Investment Management Inc. grew its position in shares of Inari Medical, Inc. (NASDAQ:NARI – Free Report) by 2.6% during the 4th quarter, according to its most recent 13F filing with ...

Inari will work with 6 Capital, successor fund 120 Capital, and VFLO Medical to distribute its venous disease tech in China.

Inari Medical has launched the Artix thrombectomy system, a medical device engineered specifically for certain requirements of the peripheral arterial system. The system is claimed to be a ...

PORTAGE, Mich., March 6, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System.

PORTAGE, Mich. – March 6, 2025 — Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System. Purpose-built for the ...

Management raised its full-year revenue guidance slightly. Inari Medical (NARI), which specializes in minimally invasive solutions to treat venous and vascular diseases, announced its second ...